The Regulatory Genome Project (RGP) announces four new participants: the Abu Dhabi Global Market Academy, Dow Jones Risk & Compliance, Invesco and Northern Trust.

The Regulatory Genome Project (RGP) announces four new participants: the Abu Dhabi Global Market Academy, Dow Jones Risk & Compliance, Invesco and Northern Trust.

The Regulatory Genome Project (RGP), a pioneering initiative to reduce fragmentation in how information about regulatory requirements is shared globally, announces a new group of participants spanning financial services, business information and financial education. 

They are:

  • Abu Dhabi Global Market Academy (ADGM Academy), a research institute and financial education provider.
  • Dow Jones Risk & Compliance, a leading provider of data and solutions for managing regulatory and reputational risk.
  • Invesco, a global independent investment management firm.
  • Northern Trust, a financial services company. 

The RGP is a collaboration between Cambridge Judge Business School and RegGenome, a spin-out company from the University of Cambridge. 

The Project supports the adoption of the Cambridge Regulatory Genome, an open information structure designed for machine learning, which will help chart the huge and expanding amount of regulatory data in the digital era. 

Industry engagement

Hamad Sayah Al Mazrouei, Managing Director of ADGM Academy, said: “We are delighted to be a part of this revolutionary project and assist in creating an inclusive repository of regulatory information for the digital economy. Our association with the Regulatory Genome Project will bolster our commitment towards delivering world-class financial knowledge, while simultaneously supporting global organisations and regulators in maintaining the status-quo amid the rapid digital and data-led evolution of the financial world.” 

“The regulatory landscape is more complex than ever before, with hundreds of updates published every day,” said Joel Lange, general manager, Dow Jones Risk & Compliance. “We are thrilled to support this important initiative, which will enable firms to better identify and interpret regulatory change and minimise the risk of non-compliance.” 

“Invesco is delighted to support the excellent work of the Cambridge Regulatory Genome Project which, as it develops further, will help financial market participants and regulators more efficiently navigate the increasingly complex world of financial regulation. We believe the Regulatory Genome will prove a vital resource for stakeholders, in particular as regulatory frameworks governing sustainable activities and digital services develop globally,” said Michael O’Shea, Senior Public Policy Manager EMEA, Invesco. 

“We are pleased to work with the University of Cambridge, the Regulatory Genome Project and other industry participants to explore opportunities to improve the accessibility of global regulatory information to regulated entities and other affected parties, which has been a long-standing challenge within the industry,” said Justin Chapman, Global Head Market Advocacy & Innovation Research, Northern Trust. 

Regulator engagement

In addition to the RGP’s new participants, the Project is also busily engaging with the regulatory community in advance of the first round of RGP Design Sprints to be held in the autumn as part of the RGP’s Regulator Engagement Programme. 

The Project is informed by regulations from more than 140 jurisdictions around the world – including securities agencies, parliaments, national banks, and state legislatures in the US – through open-source access or permissions. 

The RGP announced last year its initial four supporters: law firm CMS, professional services network Grant Thornton UK LLP, law firm Macfarlanes, and payments company Mastercard.  

Supporters of the RGP form a community in which experience and knowledge can be shared through participation in a programme of industry engagement activities. They recognise the value in the broad adoption of the Cambridge Regulatory Genome and are united in their commitment to this outcome.   

Those wishing to engage more deeply with the outputs from the Cambridge Regulatory Genome can become members of an RGP Special Interest Group (SIG), convened by RegGenome to provide a platform for collaboration around common industry challenges – and benefit from outputs such as peer-group benchmarking and common use case identification and development.